Hetrocyclic aryl sulphonamides

US7115636B2 · kind B2 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Tobias Wunberg · Mödling, AT
• Wolfgang Bender · Wuppertal, DE
• Peter Eckenberg · Wuppertal, DE
• Sabine Hallenberger · Wuppertal, DE
• Kerstin Henninger · Wuppertal, DE
• Jörg Keldenich · Wuppertal, DE
• Armin Kern · Wuppertal, DE
• Siegfried Raddatz · Hanerau-Hademarschen, DE
• Jurgen Reefschlager · Oldenburg, DE
• Gunter Schmidt · Houghton, US
• Holger Zimmermann · Falkensee, DE
• Franz Zumpe · Wuppertal, DE
• Martin Radtke · Erkrath, DE

Key dates

• Filing date: Jul 24, 2002
• Grant date: Oct 3, 2006
• Expiry date: Dec 12, 2022

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P31/18
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to novel sulfonamides of general formula (I)where the substituents R1, R2, R3, R4, A and X have the given meanings, pharmaceutical compositions containing them, and a method of using them as antiviral agents, in particular against cytomegaloviruses.